Background Factors of Reflux Esophagitis and Non-Erosive Reflux Disease: A Cross-Sectional Study of 10,837 Subjects in Japan

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Minatsuki, Chihiro ^a   Yamamichi, Nobutake ^a   Shimamoto, Takeshi ^b   Kakimoto, Hikaru ^a   Takahashi, Yu ^a   Fujishiro, Mitsuhiro ^a   Sakaguchi, Yoshiki ^a   Nakayama, Chiemi ^a   Konno Shimizu, Maki ^a   Matsuda, Rie ^a   Mochizuki, Satoshi ^a   Asada Hirayama, Itsuko ^a   Tsuji, Yosuke ^a   Kodashima, Shinya ^a   Ono, Satoshi ^a   Niimi, Keiko ^a   Mitsushima, Toru ^b   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KAMEDA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II;

ACID REGURGITATION; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL CLEARANCE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN EXPERIMENT; INFECTION; JAPAN; MALE; MICROBIOLOGICAL EXAMINATION; NON EROSIVE REFLUX DISEASE; NORMAL HUMAN; PATHOPHYSIOLOGY; POPULATION RESEARCH; PREVALENCE; PROTEIN BLOOD LEVEL; REFLUX ESOPHAGITIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; STOMACH ATROPHY; STOMACH DISEASE; STOMACH LESION; STOMACH MUCUS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ESOPHAGITIS, PEPTIC; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 84880832792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069891     Document Type: Article

References (52)

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, et al. (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101(8): 1900-1920; quiz 1943.
2. Klauser AG, Schindlbeck NE, Muller-Lissner SA, (1990) Symptoms in gastro-oesophageal reflux disease. Lancet 335(8683): 205-208.
3. Dent J, El-Serag HB, Wallander MA, Johansson S, (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54(5): 710-717.
4. El-Serag HB, Sonnenberg A, (1998) Opposing time trends of peptic ulcer and reflux disease. Gut 43(3): 327-333.
5. El-Serag HB, (2007) Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 5(1): 17-26.
6. Jung HK, (2011) Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil 17(1): 14-27.
7. Moayyedi P, Talley NJ, (2006) Gastro-oesophageal reflux disease. Lancet 367(9528): 2086-2100.
8. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr, (2006) Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 354(22): 2340-2348.
9. Zheng Z, Margolis KL, Liu S, Tinker LF, Ye W, (2008) Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux. Gastroenterology 135(1): 72-81.
10. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, et al. (1997) Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113(1): 15-24.
11. Miwa H, Go MF, Sato N, (2002) H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 97(5): 1106-1112.
12. Fujiwara Y, Arakawa T, (2009) Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol 44(6): 518-534.
13. Raghunath A, Hungin AP, Wooff D, Childs S, (2003) Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 326(7392): 737.
14. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, et al. (2001) Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 49(3): 330-334.
15. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, et al. (1999) Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 44(5): 693-697.
16. Hurwitz A, Brady DA, Schaal SE, Samloff IM, Dedon J, et al. (1997) Gastric acidity in older adults. JAMA 278(8): 659-662.
17. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, et al. (2008) Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9(3): 279-287.
18. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, et al. (2003) Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 98(4): 735-739.
19. WHO_Expert_Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403): 157-163.
20. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, et al. (1999) Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45(2): 172-180.
21. Wong WM, Wong BC, (2004) Definition and diagnosis of gastroesophageal reflux disease. J Gastroenterol Hepatol 19Suppl 3: S26-32.
22. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, et al. (1998) The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 33(10): 1023-1029.
23. Yamamichi N, Mochizuki S, Asada-Hirayama I, Mikami-Matsuda R, Shimamoto T, et al. (2012) Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of 19,864 healthy adults using FSSG scores. BMC Med 10: 45.
24. Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, et al. (2004) Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol 39(9): 888-891.
25. Peng S, Cui Y, Xiao YL, Xiong LS, Hu PJ, et al. (2009) Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. Endoscopy 41(12): 1011-1017.
26. Mishima I, Adachi K, Arima N, Amano K, Takashima T, et al. (2005) Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 40(9): 1005-1009.
27. Chung SJ, Kim D, Park MJ, Kim YS, Kim JS, et al. (2008) Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 57(10): 1360-1365.
28. Festi D, Scaioli E, Baldi F, Vestito A, Pasqui F, et al. (2009) Body weight, lifestyle, dietary habits and gastroesophageal reflux disease. World J Gastroenterol 15(14): 1690-1701.
29. Anderson LA, Cantwell MM, Watson RG, Johnston BT, Murphy SJ, et al. (2009) The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Gastroenterology 136(3): 799-805.
30. Anderson LA, Murphy SJ, Johnston BT, Watson RG, Ferguson HR, et al. (2008) Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 57(6): 734-739.
31. Kawai T, Yamamoto K, Fukuzawa M, Yamagishi T, Yagi K, et al. (2010) Helicobacter pylori infection and reflux esophagitis in young and middle-aged Japanese subjects. J Gastroenterol Hepatol 25Suppl 1: S80-85.
32. Yamaji Y, Mitsushima T, Ikuma H, Okamoto M, Yoshida H, et al. (2001) Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects. Gut 49(3): 335-340.
33. El-Serag HB, (2008) Epidemiology of non-erosive reflux disease. Digestion 78Suppl 1: 6-10.
34. Fass R, Fennerty MB, Vakil N, (2001) Nonerosive reflux disease-current concepts and dilemmas. Am J Gastroenterol 96(2): 303-314.
35. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, et al. (2005) High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 40(3): 275-285.
36. Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K, (2008) Strategy for treatment of nonerosive reflux disease in Asia. World J Gastroenterol 14(20): 3123-3128.
37. Kim N, Lee SW, Cho SI, Park CG, Yang CH, et al. (2008) The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther 27(2): 173-185.
38. Monkemuller K, Neumann H, Nocon M, Vieth M, Labenz J, et al. (2008) Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther 28(4): 491-496.
39. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, et al. (1997) Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112(5): 1442-1447.
40. Laine L, Sugg J, (2002) Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am J Gastroenterol 97(12): 2992-2997.
41. El-Serag HB, Petersen NJ, Carter J, Graham DY, Richardson P, et al. (2004) Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 126(7): 1692-1699.
42. Goh KL, (2011) Gastroesophageal reflux disease in Asia: A historical perspective and present challenges. J Gastroenterol Hepatol 26Suppl 1: 2-10.
43. Parsonnet J, (1998) Helicobacter pylori: the size of the problem. Gut 43Suppl 1: S6-9.
44. Labenz J, Jaspersen D, Kulig M, Leodolter A, Lind T, et al. (2004) Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 99(9): 1652-1656.
45. Johnson DA, Fennerty MB, (2004) Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 126(3): 660-664.
46. Pilotto A, Franceschi M, Leandro G, Scarcelli C, D'Ambrosio LP, et al. (2006) Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr Soc 54(10): 1537-1542.
47. Hampel H, Abraham NS, El-Serag HB, (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143(3): 199-211.
48. Pace F, Casini V, Pallotta S, (2008) Heterogeneity of endoscopy negative heartburn: epidemiology and natural history. World J Gastroenterol 14(34): 5233-5236.
49. Savarino E, Zentilin P, Savarino V (2013) NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol in press.
50. Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH, (2010) Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol 105(5): 1007-1013.
51. Cho YS, Choi MG, Jeong JJ, Chung WC, Lee IS, et al. (2005) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol 100(4): 747-753.
52. Wong WM, Lai KC, Lam KF, Hui WM, Hu WH, et al. (2003) Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther 2003 18(6): 595-604.